Study criteria
| Inclusion | Exclusion | |
|---|---|---|
| 1 | Adult patients (18 years or older) | Stroke as a complication/comorbidity |
| 2 | Diagnosis of stroke (including ischemic stroke, hemorrhagic stroke, or transient ischemic attack) | Studies including children or adolescents <18 years old |
| 3 | Case reports, case series, observational studies and randomized controlled trials reporting patients with stroke affected by COVID-19 | Conference proceedings, abstracts, review articles, pilot study, protocol, dissertation, letter to the editor, brief report and statement paper |
| 4 | Described in the English language | Concerns animal subjects |
| 5 | Included an outcome measure of the impact of COVID-19 on patients with stroke (e.g. stroke complication, stroke severity, mortality, hospitalization, comorbidities, or disability) |
| Inclusion | Exclusion | |
|---|---|---|
| 1 | Adult patients (18 years or older) | Stroke as a complication/comorbidity |
| 2 | Diagnosis of stroke (including ischemic stroke, hemorrhagic stroke, or transient ischemic attack) | Studies including children or adolescents <18 years old |
| 3 | Case reports, case series, observational studies and randomized controlled trials reporting patients with stroke affected by COVID-19 | Conference proceedings, abstracts, review articles, pilot study, protocol, dissertation, letter to the editor, brief report and statement paper |
| 4 | Described in the English language | Concerns animal subjects |
| 5 | Included an outcome measure of the impact of COVID-19 on patients with stroke (e.g. stroke complication, stroke severity, mortality, hospitalization, comorbidities, or disability) |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.